MAM
SAGE

Meeder Asset Management’s Sage Therapeutics SAGE Stock Holding History

Meeder Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed -$1K – 1759
2022
Q3 		$1K Hold
33
– – ﹤0.01% 2011
2022
Q2 		$1K Sell
33
-9
-21% -$302 ﹤0.01% 2070
2022
Q1 		$1K Buy
+42
New +$1.58K ﹤0.01% 2239
2021
Q4 		– Sell
-7,995
Closed -$354K – 2115
2021
Q3 		$354K Buy
7,995
+6,695
+515% +$307K 0.02% 568
2021
Q2 		$74K Buy
1,300
+1,215
+1,429% +$85.9K ﹤0.01% 997
2021
Q1 		$6K Buy
85
+1
+1% +$82 ﹤0.01% 1812
2020
Q4 		$7K Hold
84
– – ﹤0.01% 1114
2020
Q3 		$5K Buy
84
+5
+6% +$253 ﹤0.01% 1587
2020
Q2 		$3K Sell
79
-17
-18% -$617 ﹤0.01% 1691
2020
Q1 		$3K Buy
96
+24
+33% +$1.39K ﹤0.01% 1986
2019
Q4 		$5K Sell
72
-29
-29% -$3.57K ﹤0.01% 1801
2019
Q3 		$14K Sell
101
-1
-1% -$167 ﹤0.01% 1423
2019
Q2 		$19K Buy
102
+66
+183% +$11.3K ﹤0.01% 1255
2019
Q1 		$6K Buy
+36
New +$5.21K ﹤0.01% 1370
2018
Q3 		– Sell
-1,896
Closed -$297K – 1671
2018
Q2 		$297K Buy
1,896
+1,507
+387% +$237K 0.03% 446
2018
Q1 		$63K Buy
389
+210
+117% +$35.7K 0.01% 623
2017
Q4 		$29K Buy
179
+163
+1,019% +$15.8K ﹤0.01% 826
2017
Q3 		$1K Buy
+16
New +$1.26K ﹤0.01% 1562

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Meeder Asset Management's SAGE Position: Q4 2022 in Review

Meeder Asset Management sold out of Sage Therapeutics (SAGE) in Q4 2022, closing a stake of 33 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in SAGE in Q3 2017 and held it in 18 quarters. The position peaked at $354K in Q3 2021. 206 funds tracked by Wall St. Rank hold SAGE as of Q4 2022.

  • Meeder Asset Management reported no remaining Sage Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 33 Sage Therapeutics shares in Q4 2022, an estimated $1K.
  • Meeder Asset Management first reported a position in Sage Therapeutics in Q3 2017 and held it in 18 quarters.
  • Meeder Asset Management's Sage Therapeutics position peaked at $354K in Q3 2021.
  • 206 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.